Monocarboxylates have been implicated in the control of energy homeostasis. Among them, the putative role of ketone bodies produced notably during high-fat diet (HFD) has not been thoroughly explored. In this study, we aimed to determine the impact of a specific rise in cerebral ketone bodies on food intake and energy homeostasis regulation. A carotid infusion of ketone bodies was performed on mice to stimulate sensitive brain areas for 6 or 12 h. At each time point, food intake and different markers of energy homeostasis were analyzed to reveal the consequences of cerebral increase in ketone body level detection. First, an increase in food intake appeared over a 12-h period of brain ketone body perfusion. This stimulated food intake was associated with an increased expression of the hypothalamic neuropeptides NPY and AgRP as well as phosphorylated AMPK and is due to ketone bodies sensed by the brain, as blood ketone body levels did not change at that time. In parallel, gluconeogenesis and insulin sensitivity were transiently altered. Indeed, a dysregulation of glucose production and insulin secretion was observed after 6 h of ketone body perfusion, which reversed to normal at 12 h of perfusion. Altogether, these results suggest that an increase in brain ketone body concentration leads to hyperphagia and a transient perturbation of peripheral metabolic homeostasis. energy homeostasis; monocarboxylate transporters; ␤-hydroxybutyrate; obesity; glucose homeostasis DYSFUNCTION IN BOTH CEREBRAL DETECTION OF NUTRIENTS and integration of circulating signals has been implicated in the pathogenesis of obesity and associated disorders (11). For this reason, numerous studies have explored the possible role of nutrient and endocrine sensing of hypothalamic brain areas and their involvement in energy homeostasis regulation (34). The most studied circulating energy substrate is glucose, which represents a critical nutrient monitored by the brain. As the main energy source for brain cells, glucose also plays an important role in brain energy homeostasis (33). However, evidence showing that the brain can use alternative energy substrates has been provided. For instance, fatty acids and ketone bodies contribute significantly to fulfill brain energy needs under specific conditions (6, 13, 36) . Despite the fact that it has been known for decades that cerebral ketone body utilization increases under particular metabolic conditions (13), central ketone body detection has been poorly studied.
DYSFUNCTION IN BOTH CEREBRAL DETECTION OF NUTRIENTS and
integration of circulating signals has been implicated in the pathogenesis of obesity and associated disorders (11) . For this reason, numerous studies have explored the possible role of nutrient and endocrine sensing of hypothalamic brain areas and their involvement in energy homeostasis regulation (34) . The most studied circulating energy substrate is glucose, which represents a critical nutrient monitored by the brain. As the main energy source for brain cells, glucose also plays an important role in brain energy homeostasis (33) . However, evidence showing that the brain can use alternative energy substrates has been provided. For instance, fatty acids and ketone bodies contribute significantly to fulfill brain energy needs under specific conditions (6, 13, 36) . Despite the fact that it has been known for decades that cerebral ketone body utilization increases under particular metabolic conditions (13) , central ketone body detection has been poorly studied.
Under basal conditions, blood ketone body concentrations are low (Ͻ0.3 mmol/l), and their cerebral utilization is considered to be of little significance. However, ketone body levels are increased under conditions such as fasting, type 1 diabetes, or obesity (13) . The brain can use ketone bodies when their blood concentrations reach Ϸ4 mmol/l, a value close to the K m of the monocarboxylate transporter 1 (MCT1) expressed on endothelial cells of cerebral blood vessels for ketone bodies (24, 31, 44) . The brain's ability to use ketone bodies varies from one brain area to another (12) . Interestingly, the hypothalamus, which is a key player in brain sensing of metabolic signals, presents a higher ketone body metabolism than other brain areas (12) . Thus, ketone bodies could be considered a metabolic signal putatively sensed in the hypothalamus and participating in energy homeostasis control. Considering their importance for brain energetics in such circumstances, detection of their circulating levels by the brain might be quite important for homeostatic purposes, and putative defects could be involved in some metabolic disorders, including obesity.
So far, different approaches, including direct ketone body infusion into the brain parenchyma (32) , subcutaneous injection of ketone bodies (9, 32) , or ketogenic diets (5, 16, 39, 45) have been used to try to uncover the role of ketone bodies in the regulation of food intake. However, these strategies bear some caveats, as they either bypass the natural supply route, thus possibly affecting primarily other brain areas (intraparenchymal injection), or they act on other key organs for the regulation of whole body metabolism (liver, adipose tissue) and not exclusively on the brain (subcutaneous injection, ketogenic diets). Indeed, since ketone bodies are produced mainly in the liver, they must cross the blood-brain barrier to reach the brain and exert their central effects. Intracerebroventricular administration bypasses this physiological route. In addition, intraperitoneal injections or ketogenic diets affect peripheral organs as well. Finally, the direct central effect of ketone body sensing alone could not be investigated through these strategies, as ketone bodies are certainly sensed by other tissues. Altogether, these previous studies suggest an important role of ketone body detection (at both central and peripheral levels) in the regulation of energy homeostasis. However, they were not intended to decipher specifically the role of ketone bodies themselves in food intake control, as many other parameters were modified in parallel, such as fatty acid levels or blood glucose, for instance. Consequently, as described in a recent review from Paoli et al. (30) , these different studies gave rise to contradictory results regarding orexigenic vs. anorexigenic effects. On the one hand, a majority of the studies were performed through exposure to a ketogenic diet and seem to indicate that such diets are associated with decreased hunger and appetite reduction (16, 17, 28, 29, 41, 42) . Moreover, a recent study described a role of astrocytic ketone bodies and fatty acids as inhibitors of food intake during a short-term high-energy diet (23) . In contrast, ketogenic diets have been shown to induce the activation of AMP-activated protein kinase (AMPK) in brain, which is associated with an increased food intake, suggesting that brain sensing of ketone bodies could have a positive action on food intake behavior (27) . Notwithstanding, ketogenic diets cause numerous peripheral effects and alter levels of other nutrients, making it impossible to reveal the unique role of ketone bodies in brain control of food intake.
For these reasons, we investigated in this study the effect of a rise in central ketone bodies on body energy homeostasis. But in contrast to previous studies, for this purpose we used carotid-catheterized animals that were infused with ketone bodies toward the brain to mimic the normal passage via the circulation without significant changes in their concentration in the rest of the circulation, and we recorded some of their behavioral and metabolic responses.
MATERIALS AND METHODS
Animals. C57BL/6 male mice (8 wk old; Janvier) were individually housed in a controlled environment (12-h light-dark cycle, lights on at 7 AM, 22°C) with ad libitum access to food (Kliba Nafag standard diet no. 3336; Kliba Nafag, Kaiseraugst, Switzerland) and water. Ketone body infusion in unrestrained mice was done as described previously in rat and adapted for mice (26) . Briefly, after pentobarbital anesthesia (50 mg/kg), a silicone tubing (internal diameter 0.31 mm, external diameter 0.64 mm) was inserted in the right carotid and pushed 5 mm in the cranial direction. The catheter was led subcutaneously in the middle of the neck between the two blades and externalized for further connection to the infusion pump. Mice were then housed for 1 wk for surgical recovery before the infusion experiments were started. During the experiments, mice were connected to an external infusion pump, and NaCl or BHB (adjusted pH at 7.4) was infused at 30 l/h for either 6 or 12 h. All procedures involving mice followed the European Communities Council Directive (86/609/ EEC) and were approved by the Service de la Consommation et des Affaires Vétérinaires du Canton de Vaud.
Immunohistochemistry. Anesthetized neuropeptide Y (NPY)/green fluorescent protein (GFP) mice were intracardiacally perfused with 10 ml of heparin-PBS (50 U/ml) and 10 ml of 4% paraformaldehyde. Brains were then removed and preserved in 30% sucrose at 4°C, embedded in tissue-freezing medium (Jung, Nussloch, Germany), and frozen in dry ice before sectioning. Three sets of coronal sections (30 m thick) were cut on a cryostat (CM 3050S; Leica Biosystems, Dusseldorf, Germany). After three PBS rinses, sections were incubated 20 min at room temperature in 2% donkey normal serum (Sigma, Buchs, Switzerland) in 0.3% PBS Triton X-100. Sections were incubated with rabbit anti-MCT1 (1:500) (38) and goat anti-GFP (1:1,000; SicGen, Carcavelos, Portugal) for 2 days at 4°C. After three PBS rinses, sections were incubated with secondary antibodies (Jackson ImmunoResearch, Suffolk, UK) anti-goat IgG(H ϩ L) Cy3 (1:500) and anti-rabbit IgG Fab Alexa 594 (1:500) for 150 min at room temperature. Sections were incubated for 2 min in 1 g/ml Hoechst 33342 (Invitrogen, Lucerne, Switzerland) to label nuclei, mounted onto gelatin-coated glass slides, and coverslipped with Fluoromount (Sigma). Acquisitions and quantifications were performed on a laser confocal microscope (Zeiss LSM 700; Zeiss, Feldbach, Switzerland) with ϫ40 and ϫ63 objectives and using ZEN software.
Feeding test. Unrestrained mice were infused for either 6 or 12 h with a solution of 50 mM DL-␤-hydroxybutyric acid (BHB; Sigma, Buchs, Switzerland) at 30 l/h (Fig. 1A) . Such a concentration and rate allowed the animals to receive a dose of 20 g/h BHB. This concentration represents the lowest concentration tested, showing an impact on food intake but without inducing mouse sickness (determined by observing breathing difficulties and activity). The infusion started 5 h after the beginning of the dark period to avoid the increased blood ketone body levels normally induced during fasting periods and thus that could cause an increased ketone body concentration response during feeding periods, as it likely occurs in obesity or type 1 diabetes. At 6 and 12 h after the beginning of the perfusion, food intake was measured. At each time point mice were euthanized, and hypothalamus, cortex, liver, and blood were removed for further analysis.
Pyruvate and insulin tolerance tests. Mice received an intraperitoneal pyruvate (2 mg/g) or insulin injection [0.5 mU/g for insulin tolerance test (ITT) or 2 mU/g for counterregulatory response] after 6 and 12 h of ketone body infusion. Blood was collected from the tail vein at Ϫ30, 0, 15, 30, 45, 60, 90, and 120 min for determination of glucose levels.
RNA extraction, reverse transcription, and quantitative real-time PCR. Tissues were lysed and homogenized in 300 l of lysis buffer (RLT Buffer; Qiagen, Basel, Switzerland), using the Fast Prep 24 lyzer (MPbio, Lucerne, Switzerland) according to the manufacturer's instructions. Total RNA was isolated on spin columns with silicabased membranes (RNeasy Mini Kit; Qiagen), following the manufacturer's instructions. RNA was eluted with 30 l of H 2O. A small amount of purified RNA (200 ng) was reverse transcribed in a volume of 50 l using the RT High-Capacity RNA-to-cDNA Kit (Applied Biosystems, Rotkreuz, Switzerland). Synthesized cDNA was then stored at Ϫ20°C. Quantitative real-time PCR analysis was performed with the Applied Biosystems 7900 (Applied Biosystems) Real-Time PCR System. The Taq polymerase master mix employed was Power SYBR Green (Applied Biosystems). Primer sequences used for mRNA quantification were directed against NPY, agouti-related protein (AgRP), proopiomnelanocortin (POMC), cocaine-and amphetamine-related transcript (CART), ␤-hydroxybutyrate dehydrogenase (BHBDH), 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), as well as ␤2-microglobulin mRNA used as an endogenous control (primer sequences are listed in Table 1 ). Data were then analyzed with RQManager 1.2 software (Applied Biosystems) for relative quantitation (RQ). RQ of gene expression was based on the comparative CT method using the 2 Ϫ⌬⌬CT method. Blood analysis. Insulin, (Ultrasensitive Elisa Kit; Millipore, Zug, Switzerland), glucagon (glucagon RIA; Millipore), plasma lactate (The Edge blood lactate analyzer; RDSM, Hasselt, Belgium), glucose (Benecheck plus Multi-monitoring system; Benecheck, Hasselt, Belgium), and ketone body concentration (␤-hydroxybutyrate, Free Style Precision; Abbott, Baar, Switzerland) were measured after the injection at several time points using the indicated kit. Ketone bodies, lactate, and glucose were measured at the end of the perfusion from blood taken from the tail vein. Insulin and glucagon were measured in blood taken from cardiac blood withdrawal.
Liver glycogen measurement. Briefly, 100 mg of tissue stored at Ϫ80°C was homogenized in citrate buffer (50 mM NaF, 100 mM citric acid, pH 4.2) and then centrifuged at 5,000 g for 10 min at 4°C. Supernatant was removed, and 460 l was incubated with 40 l of a solution of amyloglucosidase 50 U/ml (Sigma) diluted in sodium citrate buffer, whereas 460 l was incubated with 40 l of sodium citrate buffer only. The tubes were shaken for 30 min at 55°C. Then, 10 l of each sample was deposited in 96-well plates with 200 l of a ready-to-use buffer (BioMerieux, Geneva, Switzerland) incubated at room temperature for 20 min. The optical density was read at 505 nm by spectrophotometry. The difference between conditions with amyloglucosidase and conditions with buffer represented only the glycogen content of the liver sample. Glycogen was expressed as milligrams of glucose resulting from glycogen hydrolysis per gram of tissue.
Western blot analysis. Proteins were separated with 10% SDS-PAGE. Antibodies against MCT1, MCT2, MCT4, AMPK, phosphorylated (p)-AMPK, and ␤-tubulin were used. After transfer and blocking, membranes were probed in 1% nonfat milk prepared in TBS-T with 1:1,000 rabbit anti-MCT1 and anti-MCT2 (38), 1/500 anti-MCT4 (Santa Cruz Biotechnology, Heidelberg, Germany), 1:1,000 for AMPK and p-AMPK (Cell Signaling Technology, Berverly, MA), and 1:10,000 rabbit anti-␤-tubulin (Cell Signaling Technology) overnight at 4°C. The specific band for each protein was detected using a goat anti-rabbit (1:10,000 in TBS-T-1X) peroxidase-conjugated secondary antibody (GE Healthcare, Piscataway, NJ) incubated for 1 h at room temperature. Bands were revealed with a chemiluminescence kit (Bio-Rad Laboratories, Reinach, Switzerland) and processed with a ChemiDoc XRS ϩ system (Bio-Rad) for densitometry analysis.
Electrophysiology. Brain slices (250 m) were prepared from adult NPY/GFP mice (6 -8 wk old), as described previously (7). Slices were incubated at room temperature in oxygenated extracellular medium containing (in mM): 118 NaCl, 3 KCl, 1 MgCl 2, 25 NaHCO3, 1.2 NaH2PO4, 1.5 CaCl2, 5 HEPES, and 2.5 D-glucose (osmolarity adjusted to 310 mOsM with sucrose, pH 7.3) for a recovery period (Ն60 min). Once in the recording chamber, slices were perfused at 2-3 ml/min with the same extracellular medium. Slices were viewed with a Nikon microscope (EF600) outfitted for fluorescence (fluorescein filter) and infrared-differemcial interfer- food intake determined at 6 and 12 h of NaCl or BHB infusion by subtracting the weight of the food pellets remaining at that time from the weight of food provided at the start of the experiment. C: food intake determined each hour during the first 6 h of NaCl or BHB infusion by subtracting the weight of food pellets remaining at that time from the weight of food provided at the start of the experiment. D: hypothalamic phosphorylated (p)-AMPK/AMPK protein expression ratio at 6 and 12 h in mice infused with either NaCl or BHB. Top: bands from representative samples chosen from the Western blots of all samples run in parallel and rearranged to appear side by side. Bottom: quantification of the p-AMPK/AMPK ratio. E: blood ketone body concentration at 6 and 12 h in mice infused with either NaCl or BHB. F: neuropeptide Y (NPY) mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. G: agouti-related protein (AgRP) mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. H: proopiomelanocortin (POMC) mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. I: cocaine-and amphetamine-related transcript (CART) mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. mRNA expression for each hypothalamic peptide was determined by quantitative real-time-PCR at 6, 12, and 24 h of NaCl or BHB infusion; n ϭ 8 -24 animals/condition that were statistically analyzed with unpaired Student's t-test (with Welch's correction for NPY at 6 and 12 h as well as for AgRP at 6 and 12 h). AU, arbitrary units. ence contrast videomicroscopy. Viable arcuate NPY neurons were visualized using a 60ϫ water immersion objective (Nikon) with a fluorescence video camera (Nikon). Borosilicate pipettes (4 -6 M⍀, 1.5 mm OD; Sutter Instrument) were filled with filtered extracellular medium. Cell-attached recordings were made using a Multiclamp 700B amplifier, digitized using the Digidata 1440A interface, and acquired at 3 kHz using pClamp 10.3 software (Axon Instruments). Pipettes and cell capacitances were fully compensated. After a stable baseline was established, BHB (5 mM) was perfused for 10 min. The firing activity was measured over the last minute of the BHB perfusion and compared with the firing rate measured 1 min before the perfusion.
Statistical analysis. Results are presented as means Ϯ SE. Statistical analysis was performed using Prism 6.01. Normality was tested with the Kolmogorov-Smirnov test. Depending on the result of the normality test, an unpaired Student's t-test or an unpaired t-test with Welch's correction (when equal variance was not assumed) was used. Significant differences are indicated for P values of Ͻ0.05, 0.01, or 0.001.
RESULTS

Food intake and hypothalamic neuropeptide mRNA expression in mice with intracarotid infusion of BHB.
Food intake measurement shows a significant increase in the amount of pellets ingested after 6 and 12 h of intracarotid infusion in mice receiving ␤-hydroxybutyrate compared with those receiving NaCl (1.06 Ϯ 0.07 g for the NaCl group vs. 1.32 Ϯ 0.08 g for the BHB group at 6 h, P ϭ 0.016; 1.40 Ϯ 0.09 g for the NaCl group vs. 1.62 Ϯ 0.10 g for the BHB group at 12 h, P ϭ 0.047; Fig. 1B ). Moreover, a closer analysis of the first 6 h of infusion reveals that food intake began to be significantly stimulated only after 4 h of infusion in the BHB group compared with NaCl-infused mice (0.47 Ϯ 0.04 g for the NaCl group vs. 0.70 Ϯ 0.09 g for the BHB group at 4 h, P ϭ 0.025; 0.77 Ϯ 0.05 g for the NaCl group vs. 1.04 Ϯ 0.10 g for the BHB group at 5 h, P ϭ 0.020; Fig. 1C ). Interestingly, circulating ketone body levels remained unchanged at 6 h, whereas it increased at 12 h (0.33 Ϯ 0.03 mM in the NaCl group vs. 0.42 Ϯ 0.03 mM in the BHB group; n ϭ 15 in each group, P ϭ 0.026), demonstrating that the effect observed at 6 h can be due only to ketone bodies acting at the cerebral level (Fig. 1E ). In accordance with food intake stimulation, the measurement of the p-AMPK/AMPK ratio shows an increased activation at 6 h only [0.11 Ϯ 0.03 arbitrary units (AU) for the NaCl group vs. 0.29 Ϯ 0.05 for the BHB group at 6 h, P ϭ 0.009; Fig. 1D ]. Analysis of the mRNA levels of the hypothalamic neuropeptides involved in food intake regulation revealed an increase for the orexigenic neuropeptide NPY (1.0 Ϯ 0.07 AU for the NaCl group vs. 1.46 Ϯ 0.18 AU for the BHB group at 6 h, P ϭ 0.029; 1.0 Ϯ 0.08 AU for the NaCl group vs. 1.71 Ϯ 0.21 AU for the BHB group at 12 h, P ϭ 0.012; Fig. 1F ) and AgRP (1.0 Ϯ 0.09 AU for the NaCl group vs. 2.12 Ϯ 0.33 AU for the BHB group at 6 h, P ϭ 0.005; 1.0 Ϯ 0.08 AU for the NaCl group vs. 1.63 Ϯ 0.20 AU for the BHB group at 12 h, P ϭ 0.005; Fig. 1G ). In contrast, mRNA expression of the antagonistic (and thus anorexigenic) neuropeptides POMC and CART was not altered during BHB infusion (Fig. 1, H and I, respectively).
MCT1 expression in hypothalamic orexigenic NPY neurons and their acute electrophysiological response to BHB exposure in vitro. Interestingly, the presence of MCT1 on some hypothalamic neurons had been reported previously (1) . However, the precise identity of these neurons (e.g., orexigenic vs. anorexigenic) was not provided in that study. Given our aforementioned results, it was hypothesized that hypothalamic NPY neurons could express MCT1. Immunohistochemistry performed on brain sections of NPY/GFP mice shows that almost 50% of NPY neurons were MCT1 positive (Fig. 2, A-E) . Surprisingly, however, measurements of the electrophysiological activity of arcuate NPY neurons did not reveal any direct modulation in response to shortterm BHB exposure (Fig. 2, F and G) .
Metabolic characteristics after 6 h of BHB infusion. First, different blood parameters were measured, and a twofold increase in insulin level was shown (2.20 Ϯ 1.20 ng/ml for the NaCl group vs. 5.02 Ϯ 2.39 ng/ml for the BHB group, P ϭ 0.01; n ϭ 8 NaCl-and 6 BHB-infused mice; Fig. 3A ). Despite such an increase in insulin levels, blood glucose concentration remained unaffected in the BHB group (Fig. 3B) , whereas blood lactate level was enhanced (Fig. 3C) . To test whether this apparent normoglycemia despite an increased insulin level could be due to decreased insulin sensitivity, an ITT was performed. However, the results show that BHB-infused mice instead exhibited a higher sensitivity to insulin, as shown by the lower glucose concentration induced by insulin injection [area under the curve (AUC) of 38.76 Ϯ 2.86 for the NaCl group vs. 29.19 Ϯ 1.80 for the BHB group; n ϭ 7 for each group, P ϭ 0.02; Fig. 3D, top] . These results rather suggested a putative defect in the counterregulatory response to hypoglycemia, i.e., of the glucagon release in response to hypoglycemia induced by an insulin load. Indeed, glucagon concentrations were found to be much lower in BHB-infused mice compared with the control group at 60 min after the insulininduced hypoglycemia (532 Ϯ 88 ng/l for the NaCl group vs. 134 Ϯ 50 ng/l for the BHB group; n ϭ 6 for each group, P ϭ 0.003; Fig. 3E) .
Because blood glucose level could also be influenced by neoglucogenesis, a pyruvate tolerance test was performed, and the results showed that it was reduced in BHB-infused mice (AUC of 54.50 Ϯ 3.34 for the NaCl group vs. 44.27 Ϯ 2.82 for the BHB group; n ϭ 5 for each group, P ϭ 0.047; see bar graph in Fig. 3F ). In accord with this, both mRNAs of the main enzymes involved in neoglucogenesis, PEPCK and G6Pase, were decreased in the liver, one of the major sites of neoglucogenesis (1.00 Ϯ 0.27 AU for the NaCl group vs. 0.29 Ϯ 0.03 AU for the BHB group; n ϭ 10 for each group, P ϭ 0.017 for PEPCK; and 1.00 Ϯ 0.19 AU for the NaCl group vs. 0.50 Ϯ 0.08 AU for the BHB group; n ϭ 10 for each group, P ϭ 0.026 for G6Pase; Fig. 3, G and H) . Moreover, the observed increase in lactate level (47.67 Ϯ 3.49 mg/dl for the NaCl group vs. 59.50 Ϯ 4.25 mg/dl for the BHB group; n ϭ 27 NaCl and 28 BHB mice, P ϭ 0.037) could be a consequence of decreased gluconeogenesis (Fig.  3C ). Another possible contributor to blood glucose level is hepatic glycogen. Indeed, reduced glycogen levels were found in the BHB group compared with the control group (14.60 Ϯ 1.39 g/mg tissue for the NaCl group vs. 9.59 Ϯ 1.11 g/mg tissue for the BHB group; n ϭ 11 for each group, P ϭ 0.011), suggesting the putative involvement of hepatic glycogenolysis in the maintenance of glucose homeostasis for BHB-infused animals (Fig. 3I) .
Metabolic characteristics after 12 h of BHB infusion. The same metabolic evaluation was performed after 12 h of BHB infusion. Interestingly, it was found that all the parameters measured at 12 h of BHB infusion were normalized in BHB-infused mice to the levels of the control group. Thus, glycemia, insulinemia, and lactatemia were not significantly different, and the same was true for the insulin tolerance (Fig. 4, A-D) . As expected, the counterregulatory response to hypoglycemia shows a normal glucagon release in re- . NPY/green fluorescent protein (GFP) mice were used for the labeling of the NPY neurons; n ϭ 3 mice analyzed (4 slices/mice). F: whole cell current clamp recordings of arcuate nucleus NPY neurons as extracellular BHB concentration is altered. Increased BHB had no effect on electrical activity of NPY neurons. G: quantification of action potential frequency; n ϭ 9 NPY neurons recorded from 4 male mice that were statistically analyzed with an unpaired Student's t-test. Fig. 3 . Effect of intracarotid BHB infusion on circulating nutrients and key metabolic hormone concentrations at 6 h of BHB infusion. A: insulin at 6 h in mice infused with either NaCl or BHB. B: blood glucose level at 6 h in mice infused with either NaCl or BHB. C: blood lactate level at 6 h in mice infused with either NaCl or BHB. D: intraperitoneal insulin tolerance test (ITT) performed at 6 h of BHB infusion and area under the curve (AUC) of plasma glucose levels during ITT. E: glucagon levels 60 min following an insulin-induced hypoglycemia. F: intraperitoneal pyruvate tolerance test performed at 6 h of BHB infusion and AUC of plasma glucose levels during the pyruvate tolerance test (PTT). G: liver phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression at 6 h in mice infused with either NaCl or BHB. H: liver glucose-6-phosphatase (G6Pase) mRNA expression at 6 h in mice infused with either NaCl or BHB. I: liver glycogen content determined as the glucose produced by glycogen hydrolysis at 6 h in mice infused with either NaCl or BHB; n ϭ 8 -24 animals/condition that were statistically analyzed with an unpaired Student's t-test.
Fig. 4. Effect of intracarotid BHB infusion on circulating nutrients and key metabolic hormone concentrations at 12 h of BHB infusion.
A: insulin at 12 h in mice infused with either NaCl or BHB. B: blood glucose level at 12 h in mice infused with either NaCl or BHB. C: blood lactate level at 12 h in mice infused with either NaCl or BHB. D: intraperitoneal ITT performed at 12 h of BHB infusion and AUC of plasma glucose levels during ITT. E: glucagon levels 60 min following an insulin-induced hypoglycemia. F: intraperitoneal PTT performed at 12 h of BHB infusion and AUC of plasma glucose levels during the PTT. G: liver PEPCK mRNA expression at 12 h in mice infused with either NaCl or BHB. H: liver G6Pase mRNA expression at 12 h in mice infused with either NaCl or BHB. I: liver glycogen content determined as the glucose produced by glycogen hydrolysis at 12 h in mice infused with either NaCl or BHB; n ϭ 8 -24 animals/condition that were statistically analyzed with an unpaired Student's t-test (with Welch's correction for lactatemia).
sponse to hypoglycemia (Fig. 4E) . Finally, the pyruvate injection led to a similar neoglucogenic response in BHBand NaCl-infused mice (Fig. 4F ). In accord with this, G6Pase and PEPCK mRNA levels were similar, suggesting a normalized endogenous glucose production, which is confirmed by a similar liver glycogen content (Fig. 4, G-I ) and a normalized blood lactate level (Fig. 4C) .
Hypothalamic and cortical MCT expression as well as hepatic and hypothalamic ketogenesis after BHB infusion. To verify whether exposure to BHB alters the capacity of brain cells to take up and use ketone bodies, the expression of the three main cerebral MCTs (MCT1, MCT2, and MCT4) was assessed after either 6 or 12 h of BHB infusion in both the hypothalamus and cortex. Expression levels of MCTs remained unchanged in both hypothalamic and cortical areas at 6 and 12 h of infusion (Fig. 5) . Then, the impact of cerebral BHB infusion on ketogenesis was evaluated. The expression levels of enzymes involved in ketogenesis (HMGCs2) or ketone body utilization (BHBDH) in both liver and hypothalamus were determined, and no significant changes were detected after 6 h of BHB infusion (Fig. 6, A-D) . At 12 h of BHB infusion, hypothalamic HMGCs2 mRNA levels were increased (1.00 Ϯ 0.10 AU for the NaCl group vs. 1.87 Ϯ 0.29 AU for the BHB group; n ϭ 9 for each group, P ϭ 0.013) without any other significant modification in the liver or for BHBDH mRNA in either the hypothalamus or the liver (Fig. 6, A-D) .
DISCUSSION
Monocarboxylates that include short-chain fatty acids and ketone bodies have been shown to undergo some alterations during obesity development (4, 22, 23, 43) . However, mecha- nisms by which they could be implicated in the pathophysiology of obesity have remained elusive. Nonetheless, it was postulated that ketone bodies could be involved in the regulation of food intake and in the control of energy homeostasis. Thus, in this study, ␤-hydroxybutyrate was infused via the carotid to examine the specific role of this monocarboxylate through its direct and limited action within the central nervous system in the regulation of food intake and energy homeostasis control.
Cerebral ketone body perfusion enhances food intake and hypothalamic orexigenic peptide expression. To test this hypothesis, ␤-hydroxybutyrate (BHB; 20 g/h) was infused through the carotid for either 6 or 12 h to stimulate brain areas involved in the control of energy homeostasis located primarily in the hypothalamus. The dose chosen (20 g/h) was determined after different concentrations were tested ranging from 2 to 200 g/h. A dose of 20 g/h most likely represents a high concentration compared with the concentration measured in fasting conditions. However, because the infusion is performed through the right carotid, the final concentration actually permeating the brain will be diluted by the blood coming from the left carotid and the vertebral arteries. In addition, because the rate of infusion is very low (30 l/h) compared with the carotidic blood flow (0.75 ml/min), the real BHB concentration reaching the targeted brain areas should be much lower than the concentration perfused, although it cannot be estimated precisely. Because ketogenesis occurs during the fasting period, experiments were begun during the dark period 5 h after lights off to prevent the physiological increase in ketone body levels (10).
Our main goal was to study the effect of ketone body detection by the brain independently of possible peripheral effects. Furthermore, ketone body concentration increases during high-fat diet as well as during fasting. These two metabolic conditions are in opposition with regard to the energy needs, but both are associated with increased food intake. Thus, ketone bodies could be an important signal involved in food intake stimulation. To test this hypothesis, a constant cerebral infusion of ketone bodies was administered to determine their direct involvement in food intake control. Mice infused with BHB exhibited a significant increase in food intake after 6 h. However, the stimulation of food intake appears only between 3 and 6 h. Thereafter, control and BHB mice ate the same amount of food without compensation, which led to the significant difference in food intake observed at 12 h. (Fig. 1B) . The enhancement in food intake becomes significant only after 4 h of BHB infusion, indicating a delayed effect (Fig. 1C) . A similar delay in the effect of ketone bodies was described previously in a hypothalamic cell line in which AMPK and mammalian target of rapamycin phosphorylation increased only after 4 h of incubation with BHB (20) , thus providing a putative molecular mechanism for the BHB effect on food intake. Moreover, these authors reported that activation of these cells by BHB occurs only in high-glucose conditions (20) . Thus, increased glucose oxidation induces an increase in ATP production that in turn leads first to a decrease in AMPK phosphorylation (p-AMPK). This would be consistent with our in vivo model since the experiments were performed 5 h after the start of the mouse-feeding period, which represents the period when mice eat the most (and thus should have the highest circulating blood glucose levels). Indeed, analysis of the phosphorylated/nonphosphorylated AMPK ratio shows such a cyclic activation at 6 h that is reversed at 12 h (Fig. 1D) . Subsequently, because BHB is shown to decrease glucose uptake, a resulting decrease of ATP production would ensue and lead to a delayed increase in p-AMPK only after the 4-h infusion (35) . Finally, the normalized levels of p-AMPK observed at 12 h could participate in the normalized food intake Fig. 6 . Effect of intracarotid BHB infusion on the mRNA expression of ketogenic enzymes in the hypothalamus and the liver. A: hepatic hydroxylmethylglutaryl (HMG)-CoA synthase mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. B: hypothalamic HMG-CoA synthase mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. C: hepatic BHB dehydrogenase (BHBDH) mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. D: hypothalamic BHBDH mRNA expression at 6 and 12 h in mice infused with either NaCl or BHB. Data represent means Ϯ SE; n ϭ 9 -12 animals/condition that were statistically analyzed with an unpaired Student's t-test (with Welch's correction for hypothalamic HMG-CoA synthase at 6 h).
during the 6-to 12-h period of measurements, confirming a putative biphasic effect.
These results contrast with those reported recently by Le Foll et al. (23) . Indeed, in that study, the authors described an inhibition of food intake attributed to ketone bodies. However, because they used a different model involving rats on a high-fat diet, the increase in circulating fatty acids associated with such a diet (in addition to ketone bodies) could contribute to the differential observation. In addition, as presented by these authors, the results described seem to be due to central astrocytic ketogenesis induced by fatty acid oxidation. In our case, mice were used as an animal model, and we cannot exclude a species difference. In addition, because we chose to directly infuse ketone bodies at a high concentration, the concentration reached in the brain could be too elevated to reflect a physiological effect. Moreover, our results suggest mostly that peripheral ketone body supply alone could lead to increased food intake, but the concomitant presence of elevated circulating fatty acids (as would occur physiologically on a high-fat diet) could modulate the response to elevated ketone bodies alone. Another aspect is that the origin of ketone body production (central astrocytes vs. peripheral hepatocytes) may make a difference, as astrocytes, which can modulate neuronal functions, could have seen such a modulatory role influenced by exposure to high ketone body levels. Thus, further investigations are needed to clarify the role of central vs. peripheral ketogenesis. Finally, the differences found in the previous study from Le Foll et al. (23) and ours could also be due to differences in exposure time scales. Because we investigated short-term (12 h) infusion of ketone bodies alone to determine the single effect of ketone bodies vs. 3 days of a high-fat diet inducing an increase in both ketone bodies and fatty acids for the study of Le Foll et al. (23) , the different results obtained could reflect biphasic effects of ketone bodies on food intake regulation and/or a role of fatty acids overriding the ketone body effect. Notably, our results would be consistent with a rapid, short-term effect, as food intake stimulation takes place mostly within the first 6 h of perfusion. A more prolonged cerebral infusion should be performed in the future to clearly determine whether such a biphasic effect occurs.
Since the carotid infusion of BHB most likely affects, among other things, brain regions such as the hypothalamus, a well-known center for energy homeostasis regulation (2), the mRNA levels of the main neuropeptides involved in food intake control were assessed. An increase in the expression of the orexigenic neuropeptides NPY and AgRP was observed (Fig. 1, F and G) , without any significant modification in the anorexigenic neuropeptides POMC and CART (Fig. 1, H and I) after both 6 and 12 h of BHB infusion. Such an overexpression of orexigenic neuropeptides induced by ketone bodies had been described previously both in vitro in the hypothalamic GT1-7 cell line and in vivo in diabetic rats (14, 20) . However, it is demonstrated here that ketone bodies stimulate orexigenic neuropeptide mRNA expression also under physiological conditions in vivo. This result confirms that ketone bodies can stimulate directly the orexigenic neurocircuits in vivo.
A large subpopulation of hypothalamic NPY neurons expresses the transporter MCT1. Ketone bodies are transported in and out of cells by a small group of proteins known as MCTs. MCT1 is the first identified member of this group and exhibits a large distribution in the body as well as among brain cells (37) . Interestingly, the presence of MCT1 on some hypothalamic neurons had been reported previously (1) . However, the precise identity of these neurons (e.g., orexigenic vs. anorexigenic) was not provided in that study. Given our aforementioned results, it was hypothesized that hypothalamic NPY neurons could express MCT1. Immunohistochemistry performed on brain sections of NPY/GFP mice shows that almost 50% of NPY neurons were MCT1 positive (Fig. 2, A-E) . As reported previously (34), brain capillaries (like here in the hypothalamus) strongly express MCT1, a situation that would facilitate the entry of ketone bodies in the brain parenchyma, notably for use as alternative energy fuel by brain cells. In the hypothalamus, NPY neurons expressing MCT1 could be responsible for the enhanced orexigenic activity following BHB infusion by exhibiting a direct sensitivity to circulating ketone bodies. Recently, a mouse model haploinsufficient for MCT1 displaying a resistance to diet-induced obesity and altered food intake has been described, suggesting an important role for monocarboxylates in the regulation of body weight and energy homeostasis regulation (25) . Based on the immunocytochemical data presented here, it is postulated that a subpopulation of hypothalamic neurons would be sensitive to circulating ketone bodies and could be responsible for the regulation of food intake that appears altered in haploinsufficient MCT1 mice.
Surprisingly, measurements of the electrophysiological activity of arcuate NPY neurons did not reveal any direct modulation in response to BHB (Fig. 2, F and G) . In contrast, a recent study using calcium imaging showed that hypothalamic neurons are activated by an increase in BHB concentration (23) . However, in that study the authors did not characterize the specific phenotype of these neurons. In our study, BHB failed to alter the electrophysiological activity of all NPY neurons tested. Such an absence of electrophysiological response from these neurons to ketone bodies could be due to the short duration of exposure and measurement used in our experiment (10 min). Indeed, as described above, the stimulatory effect of BHB on food intake appears only after 4 h of treatment. The same time course was also described for the response in vitro (20) . Thus, an acute exposure of brain slices to BHB might not be sufficient to observe any long-term changes in electrophysiological activity. In addition, the denervation of NPY neurons in slices could also explain the lack of response observed upon application of BHB. Removal of inhibition of this population would lead to such a high spontaneous firing rate that it would make BHB-induced changes undetectable. Nevertheless, despite the orexigenic effect of ketone bodies observed here and the lack of effect on POMC mRNA expression, we cannot exclude a putative action on POMC neurons that needs to be further explored.
Cerebral ketone body perfusion causes a transient rise in insulin level and a decrease in hepatic gluconeogenesis. Circulating insulin levels were significantly elevated after 6 h of cerebral BHB perfusion (Fig. 3A) , whereas blood glucose was not altered in such a condition compared with control mice (Fig. 3B) . Because insulin is known to inhibit food intake when infused in the hypothalamus (40) , an eventual brain response to insulin seems counterbalanced by the direct central action of ketone bodies. Ketone bodies, by inducing insulin secretion and stimulating food intake at the same time, appear to have an antagonistic role in central energy homeostasis regulation. A possible explanation could be through a redox signaling mech-anism. Indeed, food intake inhibition by insulin was shown to involve an increase of reactive oxygen species production in the hypothalamus (15) . In contrast, ketone bodies were shown to reduce reactive oxygen species production in neurons by acting on mitochondrial function (18) . Thus, cerebral infusion of ketone bodies could interfere with insulin signaling, leading to food intake stimulation by preventing reactive oxygen species production in hypothalamic neurons. Because these observations suggested the possible early development of insulin resistance, an insulin tolerance test was performed on mice after 6 h of BHB perfusion. Surprisingly, the results rather revealed a more sensitive response to insulin in these animals (Fig. 3D) . One possible explanation for the enhanced reduction in glucose concentration obtained during the insulin tolerance test is an alteration of counterregulatory responses to hypoglycemia. Indeed, when the counterregulation was evaluated following an important insulin injection, lower levels of glucagon were observed after 6 h of cerebral BHB perfusion compared with control animals (Fig. 3E) . Interestingly, this reduced glucagon release is observed at 60 min after insulin injection, a time when glucose concentration rises to normal values in control animals. Such an observation strongly suggests that insulin sensitivity is not altered but that counterregulatory response is missing. This response obtained with BHB is similar to the inhibited counterregulation observed with central application of lactate (also carried by the MCTs) (3). It is important to note, since a counterregulatory response normally occurs in a decreased energy availability condition, that the results here seem contradictory with the food intake stimulation observed in parallel. However, it is likely that different neuronal populations are involved in these responses. Indeed, if food intake control is regulated by NPY neurons in the arcuate nucleus, the counterregulatory response is suggested to be regulated at the level of the ventromedial nucleus, another hypothalamic nucleus (8) . However, in view of such contradictory observations, further investigations will be required to determine the precise mechanisms involved.
To further explore the impact on counterregulation, a pyruvate tolerance test was performed on mice after 6 h of BHB perfusion. A reduced hepatic gluconeogenesis was revealed in animals after 6 h of BHB perfusion compared with control animals, as evidenced by lower circulating glucose levels obtained following pyruvate injection (Fig. 3F ). In accord with reduced hepatic gluconeogenesis, a reduction in the mRNA expression of G6Pase (Fig. 3H) and PEPCK (Fig. 3G) was shown in the liver of animals perfused with BHB compared with controls. In parallel, it was observed that blood lactate level was enhanced whereas liver glycogen levels were reduced in mice perfused with BHB. Because G6Pase is common to gluconeogenesis and glycogenolysis, which classically leads to glucose release, it appears in our case that the observed glycogen breakdown would not lead to glucose release but rather to a glycolytic processing of glucose residues arising from glycogen. In other words, the observed glycogen degradation would lead to a hepatic lactate production, thus explaining the increased lactate level, reinforced by the decreased gluconeogenesis that would prevent hepatic lactate utilization and rather promote circulating lactate accumulation. Such an effect could be the consequence of elevated insulin levels and sensitivity, as hyperinsulinemia was shown previously to inhibit hepatic gluconeogenesis (19) .
In contrast to the observation made after 6 h, insulin level was no longer altered after 12 h of BHB perfusion (Fig. 4A) , whereas blood glucose level was still normal (Fig. 4B) . Similarly, the insulin tolerance test showed that insulin sensitivity was not different between BHB-infused animals and control animals (Fig. 4D) . When the counterregulatory response was evaluated, again no difference in glucagon levels (Fig. 4E) was detected. The pyruvate tolerance test did not reveal any difference in gluconeogenesis (Fig. 4F ) after 12 h of BHB perfusion. In the liver, both G6Pase and PEPCK mRNA levels were the same between control and BHB-infused mice (Fig. 4, G and  H) . In parallel, both circulating lactate concentration and hepatic glycogen levels were similar for control and BHB-infused mice, thus confirming that after 12 h of BHB perfusion, all parameters returned to normal levels. These data underline the transient nature of the changes induced by central ketone body infusion despite a constant exposure to them, suggesting some forms of central desensitization or habituation. Since it was shown previously that the level of expression of all three cerebral MCT isoforms was modified as a consequence of obesity (36) , a possible effect of cerebral BHB perfusion on MCT expression either in the hypothalamus or in the cortex was investigated. The results obtained at the protein levels for MCT1, -2, and -4 did not reveal any modification of expression following the infusion of BHB in either the hypothalamus or the cortex (Fig. 5 ). This result is not surprising when considering that it took several weeks of high-fat diet to observe a significant enhancement in the cerebral expression of MCTs (25) . Nevertheless, our results suggest that hypothalamic (and cortical) ketone body transport is not altered during this relatively short cerebral exposure to ketone bodies, although we cannot exclude a hypothetic posttranslational modification of the transporters. Because the hypothalamus represents a key brain region for the regulation of body energy homeostasis, several peripheral metabolic markers were analyzed to further determine the impact of cerebral BHB infusion on peripheral metabolism. Hence, the concentration of several circulating metabolites and hormones was measured. First of all, ketone body concentration measured after 6 h of central BHB perfusion was not modified compared with controls, indicating that the observed effects are due to the exogenous cerebral BHB infusion (Fig.  1E) . At 12 h of BHB infusion, an increase in ketone body concentration was detected (Fig. 1E) . However, mRNA expression levels for HMG-CoA synthase, the rate-limiting enzyme involved in ketogenesis, did not show any alteration in the liver (the main ketogenic organ; Fig. 6B ) (21) . Thus, the elevated circulating ketone body level observed after 12 h of BHB infusion is most likely due to BHB accumulation in the systemic circulation following carotid infusion for such an extended period. More surprisingly, HMG-CoA synthase mRNA levels increased in the hypothalamus after 12 h but not after 6 h of cerebral BHB perfusion (Fig. 6C) . In parallel, mRNA expression levels for BHBDH (the essential enzyme for ketone body utilization) were analyzed, but no modification was observed at any time point in either the liver or the hypothalamus (Fig. 6, C and D) . Since the rate-limiting enzyme for ketone body synthesis is not affected at 6 h, it suggests that the increased food intake (which is significant already at 6 h) is dependent on the exogenous ketone body infusion and not on hypothalamic ketogenesis. In addition, these results do not support a local or global decrease in ketone body utilization. Thus, the most likely explanation for the measured increased ketone body concentration remains a consequence of the carotid-infused BHB on the global blood concentration. Brain ketogenesis can produce only low concentrations of ketone bodies, as measured in a recent study in the ventromedial hypothalamus (VMH) in which the authors measured a concentration of ϳ20 M, when the blood concentration can be up to 300 M (23). It can be concluded that such a small local VMH production is unlikely to contribute significantly to the increased circulating ketone bodies observed in mice after 12 h of BHB perfusion.
To summarize, this study provides evidence that the simulated elevated cerebral ketone body concentration induces specific brain responses that lead to a transient increase in food intake and peripheral energy metabolism alterations. These modifications include decreased hepatic glucose production after glycogen hydrolysis. Thus, ketone bodies sensed by the brain seem to represent an energetic stress signal that leads to energy intake to maintain physiological functions. It is accompanied by transient peripheral metabolic responses triggered via the hypothalamus since the observed phenotype is reversed if the BHB infusion lasts up to 12 h (Fig. 7) . In conclusion, we demonstrate here that ketone bodies represent an important signal that leads to energy preservation and supply, as they stimulate adaptive responses to compensate for a perceived energy deficit.
